Sartorius sets up Life Science Factory for startup entrepreneurs
Life Science Factory gGmbH offers labs, co-working spaces and consulting services for life science entrepreneurs.
With its newly founded, independent Life Science Factory, Sartorius intends to promote startups and attract entrepreneurs from the life science sector.
Life Science Factory offers space and support to prospective scientific entrepreneurs and young companies willing to take their first steps beyond the comfort zone of academic institutions. Based on an exemplary business model already established in the US as a launch pad for life science startups, the Life Science Factory strategy provides for the interaction of lab areas, coworking rooms and network offerings, such as mentoring and company financing. The firm’s professional operating concept ensures efficient facility management and administrative support, high-quality laboratory equipment and qualified lab staff.
“In this combination, such an approach is new in Germany and other European countries,” comments Sartorius Executive Board Chairman and CEO Joachim Kreuzburg. “Life science startups primarily lack suitable lab facilities and a powerful network, apart from access to startup and growth capital. Flexible and open-design spaces for labs, offices and events are a good breeding ground for trying out new things and sharing contacts and experiences with like-minded peers and veteran founders.“ He says that Life Science Factory is intended to propel Göttingen beyond its reputation focusing on scientific expertise, establishing the city as a genuine hotspot for life science startups. The managing directors of Life Science Factory gGmbH, a non-profit, are entrepreneur and founder Marco Janezic and Sven Wagner, who heads the Business Development unit at Sartorius and had previously worked at two life science startups.
Life Science Factory will work closely with local partners, such as Göttingen’s universities, MaxPlanck institutes and the Southern Lower Saxony Innovation Campus, SNIC, and, beyond these, with its wider network. For example, the non-profit will be the venue for startup activities of the Fraunhofer-Gesellschaft, Europe’s largest application-oriented research organization, such as Fraunhofer Life Science Days, or for the initiative of the Young Entrepreneurs in Science of the Falling Walls Foundation. “Göttingen has the potential and the opportunity to achieve a much stronger position in this extremely dynamic and socially important field than has been the case so far,” says Kreuzburg.
The non-profit will be ready to start off in early 2019: Office space in the inner city of Göttingen will be available on more than 500 m2 for co-working, experiments and events, and can be rented by entrepreneurs for working and prototype building. The offices will also offer the latest equipment, such as 3-D printers and laser cutters. In addition, lectures to be held by patent attorneys or successful startup founders, for instance, are scheduled as are further events addressing startup issues. Any earnings generated by Life Science Factory will be reinvested in the promotion of knowledge transfer and of young scientists and researchers.
In 2021, Life Science Factory plans to move to the new Sartorius Quarter. Providing a total area of more than 3,000 square meters, the new facility for Life Science Factory will be one of the first buildings to open in the new city quarter at the previous Sartorius site. “Our former company headquarters was always a place of taking entrepreneurial initiative and of turning science into practical industrial solutions, especially in life sciences. For this reason, the Sartorius Quarter is also designed to continue as a place for ideas and innovations in the future as well. Through this Life Science Factory, our company is upholding its long-term commitment to this location and thus to also close a gap in Göttingen,” says Kreuzburg. At the end of 2017, Sartorius relocated its headquarters after operating for some 120 years at its traditional site in the inner city of Göttingen to Sartorius Campus in the Göttingen-Grone industrial zone.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance